This profile has not been claimed and data may not be accurate.
35th percentile
Columbia radiology professor and Division Chief pioneering breast imaging AI
Credibility
Domain Expertise · 85th percentile
- Deep research credibility: h-index 70 with 14,616 citations across 478 works (OpenAlex).
- Identified researcher with a strong academic footprint at Columbia University Irving Medical Center and Memorial Sloan Kettering Cancer Center.
Relationship Matrix
Most Like You
Most Complimentary
Founder score
- 95%Probability of being accurate (95%)Internationally renowned physician-scientist and professor of radiology at Columbia University Irving Medical Center, serving as chief of the Division of Breast Imaging.
- 95%Probability of being accurate (95%)Identified researcher with a strong academic footprint at Columbia University Irving Medical Center and Memorial Sloan Kettering Cancer Center.
- 90%Probability of being accurate (90%)Deep research credibility: h-index 70 with 14,616 citations across 478 works (OpenAlex).
What you likely need
You sit at a rare intersection of world-class clinical credibility and emerging AI expertise, making you an ideal candidate for events that bridge academic medicine and the venture-backed health tech ecosystem. The most valuable Festival gatherings for you are intimate dinners and roundtables where femtech and medical imaging AI founders, oncology-focused VCs, and clinical AI advisors can immediately recognize your h-index-70 signal and translate it into board seats, consulting mandates, or spinout conversations. You'll get the most traction in rooms where your Columbia and MIT Sloan affiliations open doors to commercialization and thought leadership opportunities that pure academics rarely access.
Would you attend these IRL Festival events?
We will tune and customize your Founder Festival experience to make sure you get invited to the events that would be most valuable to you.
- introsA femtech founder dinner with clinical AI advisory board members from companies like Seer Bio, Hologic, and iCAD to explore formal advisory roles where your breast imaging expertise and h-index 70 are immediately legible as a differentiator
- introsA roundtable with oncology-focused VCs actively backing clinical AI portfolio companies (including funds behind Sidekick Health and Viz.ai) who are acquiring physician-scientist advisors with FDA-navigable clinical validation credentials
- fundraisingA Columbia Technology Ventures alumni dinner for faculty founders who have successfully licensed or spun out imaging or diagnostics IP, to pressure-test a breast imaging AI commercialization path with people who have navigated the same TTO process
- tacticalAn MIT Sloan Health Innovation certificate alumni happy hour connecting physician-scientists and health tech operators to surface consulting and advisory mandates at medical device and imaging AI companies
- fundraisingA tactical roundtable with NCI R01 and U01 principal investigators who have successfully layered industry partnerships on top of federal grants, to map a dual-track funding strategy for AI-driven breast cancer screening research
- positioningA positioning workshop for physician-scientists building public audiences on LinkedIn and in outlets like STAT News, focused on translating peer-reviewed breast imaging and clinical AI credentials into thought leadership that attracts speaking invitations and board inquiries
- tacticalA dinner for senior clinician-consultants advising medical device and imaging AI companies on FDA 510(k) and De Novo regulatory strategy, to help formalize a consulting practice built on your 24-plus years of clinical validation experience